APO RESEARCH · REPORT
Ceftriaxone Sodium
Ceftriaxone sodium is a cephalosporin antibiotic.
Product & engineering
Understand the product.
Ceftriaxone sodium is a cephalosporin antibiotic.
Selected research
Industry Research
Ceftriaxone Sodium Industry Research Report 2026
Market perspective
Ceftriaxone sodium is a cephalosporin antibiotic.
There are three kinds of Ceftriaxone Sodium, which are ChP, USP and EP. ChP hold the largest share of the Ceftriaxone Sodium market, with a sales market share nearly 74% in 2019.
Ceftriaxone Sodium is used in Single Injection and Compound Injection. The most proportion of Ceftriaxone Sodium is used in Single Injection, and the market share in 2019 is about 96%.
Read the full market overview
Asia-Pacific is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 12%.
For the production, China and India are the mainly manufactured base.
Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, etc. are the leader of the industry, and top 5 players hold about 50% revenue market share.
Report Scope
This report quantifies the global Ceftriaxone Sodium market in terms of revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ceftriaxone Sodium Market by Company
Shandong Ruiying
Qilu Antibiotics
Nectar Lifesciences
Kelun
United Laboratories
Aurobindo Pharma
Orchid Pharma
Medya Pharma
REYOUNG
LKPC
ACS Dobfar
NCPC
Dawnrays
Kopran
Ceftriaxone Sodium Segment by Type
ChP
USP
EP
Ceftriaxone Sodium Segment by Application
Single Injection
Compound Injection
Ceftriaxone Sodium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceftriaxone Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ceftriaxone Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceftriaxone Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ceftriaxone Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ceftriaxone Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ceftriaxone Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ChP
- USP
- EP
Applications
- Single Injection
- Compound Injection
Companies covered
- Shandong Ruiying
- Qilu Antibiotics
- Nectar Lifesciences
- Kelun
- United Laboratories
- Aurobindo Pharma
- Orchid Pharma
- Medya Pharma
- REYOUNG
- LKPC
- ACS Dobfar
- NCPC
- Dawnrays
- Kopran
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ceftriaxone Sodium Market Size (2021-2032)
- 2.2.2 Global Ceftriaxone Sodium Sales (2021-2032)
- 2.2.3 Global Ceftriaxone Sodium Market Average Price (2021-2032)
- 2.3 Ceftriaxone Sodium by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 ChP
- 2.3.3 USP
- 2.3.4 EP
- 2.4 Ceftriaxone Sodium by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Single Injection
- 2.4.3 Compound Injection
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ceftriaxone Sodium Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ceftriaxone Sodium Sales (MT) of Manufacturers (2021-2026)
- 3.3 Global Ceftriaxone Sodium Revenue of Manufacturers (2021-2026)
- 3.4 Global Ceftriaxone Sodium Average Price by Manufacturers (2021-2026)
- 3.5 Global Ceftriaxone Sodium Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ceftriaxone Sodium, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ceftriaxone Sodium, Product Type & Application
- 3.8 Global Manufacturers of Ceftriaxone Sodium, Established Date
- 3.9 Global Ceftriaxone Sodium Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shandong Ruiying
- 4.1.1 Shandong Ruiying Company Information
- 4.1.2 Shandong Ruiying Business Overview
- 4.1.3 Shandong Ruiying Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shandong Ruiying Ceftriaxone Sodium Product Portfolio
- 4.1.5 Shandong Ruiying Recent Developments
- 4.2 Qilu Antibiotics
- 4.2.1 Qilu Antibiotics Company Information
- 4.2.2 Qilu Antibiotics Business Overview
- 4.2.3 Qilu Antibiotics Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Qilu Antibiotics Ceftriaxone Sodium Product Portfolio
- 4.2.5 Qilu Antibiotics Recent Developments
- 4.3 Nectar Lifesciences
- 4.3.1 Nectar Lifesciences Company Information
- 4.3.2 Nectar Lifesciences Business Overview
- 4.3.3 Nectar Lifesciences Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Nectar Lifesciences Ceftriaxone Sodium Product Portfolio
- 4.3.5 Nectar Lifesciences Recent Developments
- 4.4 Kelun
- 4.4.1 Kelun Company Information
- 4.4.2 Kelun Business Overview
- 4.4.3 Kelun Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Kelun Ceftriaxone Sodium Product Portfolio
- 4.4.5 Kelun Recent Developments
- 4.5 United Laboratories
- 4.5.1 United Laboratories Company Information
- 4.5.2 United Laboratories Business Overview
- 4.5.3 United Laboratories Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 United Laboratories Ceftriaxone Sodium Product Portfolio
- 4.5.5 United Laboratories Recent Developments
- 4.6 Aurobindo Pharma
- 4.6.1 Aurobindo Pharma Company Information
- 4.6.2 Aurobindo Pharma Business Overview
- 4.6.3 Aurobindo Pharma Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Aurobindo Pharma Ceftriaxone Sodium Product Portfolio
- 4.6.5 Aurobindo Pharma Recent Developments
- 4.7 Orchid Pharma
- 4.7.1 Orchid Pharma Company Information
- 4.7.2 Orchid Pharma Business Overview
- 4.7.3 Orchid Pharma Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Orchid Pharma Ceftriaxone Sodium Product Portfolio
- 4.7.5 Orchid Pharma Recent Developments
- 4.8 Medya Pharma
- 4.8.1 Medya Pharma Company Information
- 4.8.2 Medya Pharma Business Overview
- 4.8.3 Medya Pharma Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Medya Pharma Ceftriaxone Sodium Product Portfolio
- 4.8.5 Medya Pharma Recent Developments
- 4.9 REYOUNG
- 4.9.1 REYOUNG Company Information
- 4.9.2 REYOUNG Business Overview
- 4.9.3 REYOUNG Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 REYOUNG Ceftriaxone Sodium Product Portfolio
- 4.9.5 REYOUNG Recent Developments
- 4.10 LKPC
- 4.10.1 LKPC Company Information
- 4.10.2 LKPC Business Overview
- 4.10.3 LKPC Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 LKPC Ceftriaxone Sodium Product Portfolio
- 4.10.5 LKPC Recent Developments
- 4.11 ACS Dobfar
- 4.11.1 ACS Dobfar Company Information
- 4.11.2 ACS Dobfar Business Overview
- 4.11.3 ACS Dobfar Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 ACS Dobfar Ceftriaxone Sodium Product Portfolio
- 4.11.5 ACS Dobfar Recent Developments
- 4.12 NCPC
- 4.12.1 NCPC Company Information
- 4.12.2 NCPC Business Overview
- 4.12.3 NCPC Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 NCPC Ceftriaxone Sodium Product Portfolio
- 4.12.5 NCPC Recent Developments
- 4.13 Dawnrays
- 4.13.1 Dawnrays Company Information
- 4.13.2 Dawnrays Business Overview
- 4.13.3 Dawnrays Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Dawnrays Ceftriaxone Sodium Product Portfolio
- 4.13.5 Dawnrays Recent Developments
- 4.14 Kopran
- 4.14.1 Kopran Company Information
- 4.14.2 Kopran Business Overview
- 4.14.3 Kopran Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Kopran Ceftriaxone Sodium Product Portfolio
- 4.14.5 Kopran Recent Developments
5 Global Ceftriaxone Sodium Market Scenario by Region
- 5.1 Global Ceftriaxone Sodium Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ceftriaxone Sodium Sales by Region: 2021-2032
- 5.2.1 Global Ceftriaxone Sodium Sales by Region: 2021-2026
- 5.2.2 Global Ceftriaxone Sodium Sales by Region: 2027-2032
- 5.3 Global Ceftriaxone Sodium Revenue by Region: 2021-2032
- 5.3.1 Global Ceftriaxone Sodium Revenue by Region: 2021-2026
- 5.3.2 Global Ceftriaxone Sodium Revenue by Region: 2027-2032
- 5.4 North America Ceftriaxone Sodium Market Facts & Figures by Country
- 5.4.1 North America Ceftriaxone Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ceftriaxone Sodium Sales by Country (2021-2032)
- 5.4.3 North America Ceftriaxone Sodium Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Ceftriaxone Sodium Market Facts & Figures by Country
- 5.5.1 Europe Ceftriaxone Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ceftriaxone Sodium Sales by Country (2021-2032)
- 5.5.3 Europe Ceftriaxone Sodium Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Ceftriaxone Sodium Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ceftriaxone Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ceftriaxone Sodium Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ceftriaxone Sodium Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ceftriaxone Sodium Market Facts & Figures by Country
- 5.7.1 South America Ceftriaxone Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ceftriaxone Sodium Sales by Country (2021-2032)
- 5.7.3 South America Ceftriaxone Sodium Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Ceftriaxone Sodium Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ceftriaxone Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ceftriaxone Sodium Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ceftriaxone Sodium Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Ceftriaxone Sodium Sales by Type (2021-2032)
- 6.1.1 Global Ceftriaxone Sodium Sales by Type (2021-2032) & (MT)
- 6.1.2 Global Ceftriaxone Sodium Sales Market Share by Type (2021-2032)
- 6.2 Global Ceftriaxone Sodium Revenue by Type (2021-2032)
- 6.2.1 Global Ceftriaxone Sodium Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ceftriaxone Sodium Revenue Market Share by Type (2021-2032)
- 6.3 Global Ceftriaxone Sodium Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ceftriaxone Sodium Sales by Application (2021-2032)
- 7.1.1 Global Ceftriaxone Sodium Sales by Application (2021-2032) & (MT)
- 7.1.2 Global Ceftriaxone Sodium Sales Market Share by Application (2021-2032)
- 7.2 Global Ceftriaxone Sodium Revenue by Application (2021-2032)
- 7.2.1 Global Ceftriaxone Sodium Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ceftriaxone Sodium Revenue Market Share by Application (2021-2032)
- 7.3 Global Ceftriaxone Sodium Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ceftriaxone Sodium Value Chain Analysis
- 8.1.1 Ceftriaxone Sodium Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ceftriaxone Sodium Production Mode & Process
- 8.2 Ceftriaxone Sodium Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ceftriaxone Sodium Distributors
- 8.2.3 Ceftriaxone Sodium Customers
9 Global Ceftriaxone Sodium Analyzing Market Dynamics
- 9.1 Ceftriaxone Sodium Industry Trends
- 9.2 Ceftriaxone Sodium Industry Drivers
- 9.3 Ceftriaxone Sodium Industry Opportunities and Challenges
- 9.4 Ceftriaxone Sodium Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst